nivolumab,ipilimumab
bms
['nivo', 'ipi/', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
great to present our phase 2 studies of ipi/nivo+rt in mss pdac and crc at #asco23. very grateful for our patients and the best mentors and team! 
PGY-4 resident @HarvardRadOnc via @sloan_kettering @StanfordMed @Stanford @StanfordSquash @CampKesem. Views my own.